Le Lézard

Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan

Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, and Eisai Co., Ltd (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai"), a ...
Scientific Research Publishing

Intelligent Monitoring of Methane at a Reclaimed Landfill Wasteland Transformed into a Valuable Public Park ()

Jjemba, P. and Mercado, R. (2026) Intelligent Monitoring of Methane at a Reclaimed Landfill Wasteland Transformed into a ...

Share Market Highlights 13th January 2026: Stock markets end lower on foreign fund outflows, selling in blue-chips

Share Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock ...

Mayfair Delivers Robust Pre-Feasibility Study for the Fenn-Gib Gold Project

Mayfair Gold Corp. ("Mayfair", "Mayfair Gold" or the "Company") (TSXV: MFG) (OTCQX: MFGCF) is pleased to announce the results ...
Le Lézard

Persistent Corneal Edema Market to Show Impressive Growth at a CAGR of 21.8% During the Forecast Period (2025-2034) | DelveInsight

DelveInsight's Persistent Corneal Edema Market Insights report includes a comprehensive understanding of current treatment practices, persistent corneal edema emerging drugs, market share of ...
EuropaWire

Researchers Invited to Apply for Demonstrator 2026 Funding to Accelerate Market Readiness

The Demonstrator 2026 call has opened with more than €1.2 million in funding available to support researchers in transforming academic knowledge into market-ready products or services, offering up to ...